These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 6770953

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Penicillamine in rheumatic diseases: a prospective study of tolerance and efficacy.
    Munthe E, Kåss E.
    J Rheumatol Suppl; 1981; 7():107-11. PubMed ID: 6785435
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
    Scherak O, Smolen JS, Mayr WR, Mayrhofer F, Kolarz G, Thumb NJ.
    J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HLA antigens and adverse drug reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Dahlqvist SR, Ström H, Bjelle A, Möller E.
    Clin Rheumatol; 1985 Mar; 4(1):55-61. PubMed ID: 3157529
    [Abstract] [Full Text] [Related]

  • 9. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine.
    Redda A, Anastassiades T.
    Clin Invest Med; 1984 Mar; 7(1):65-71. PubMed ID: 6426836
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D, Brook A, Brooks P, Boyden K, Thomas D, Tymms K.
    J Rheumatol Suppl; 1982 Mar; 8():197-200. PubMed ID: 6813485
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. HLA-A,-B, and -DR antigens in relation to gold and D-penicillamine toxicity in Greek patients with RA.
    Pachoula-Papasteriades C, Boki K, Varla-Leftherioti M, Kappos-Rigatou I, Fostiropoulos G, Economidou J.
    Dis Markers; 1986 Jun; 4(1-2):35-41. PubMed ID: 3133153
    [Abstract] [Full Text] [Related]

  • 15. Should one use second-line agents such as gold and D-penicillamine in a patient with active rheumatoid arthritis and asymptomatic microscopic haematuria for which no cause can be determined?
    Bird HA.
    Br J Rheumatol; 1989 Feb; 28(1):39. PubMed ID: 2492869
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
    Leonard PA, Bienz SR, Clegg DO, Ward JR.
    J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
    [Abstract] [Full Text] [Related]

  • 20. Sequential gold and penicillamine therapy in rheumatoid arthritis.
    Halla JT, Cassady J, Hardin JG.
    Am J Med; 1982 Mar; 72(3):423-6. PubMed ID: 6174045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.